SREBF1 and colorectal carcinoma: SREBP-1 silencing decreases the levels of fatty acid and SREBP-1 targets genes to inhibit the initiation and tumor progression of CRC, which might be associated with the alternation of cellular metabolism, including mitochondrial respiration, glycolysis, and fatty acid oxidation (64).